We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+18.51%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
10 Year Est. Return
AUM
$207M
AUM Growth
+$19.7M
Cap. Flow
-$2.22M
Cap. Flow %
-1.07%
Top 10 Hldgs %
43.03%
Holding
83
New
21
Increased
16
Reduced
17
Closed
24

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$7.25M
2
IONS icon
Ionis Pharmaceuticals
IONS
+$3.3M
3
ABBV icon
AbbVie
ABBV
+$3.15M
4
ZBH icon
Zimmer Biomet
ZBH
+$2.71M
5
DXCM icon
DexCom
DXCM
+$2.6M

Sector Composition

Rank Sector Weight
1 Healthcare 70.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
1
Biogen
BIIB
$30.8B
$13.6M 6.56%
40,000
-2,500
-6% -$809K
CELG
2
DELISTED
Celgene Corp
CELG
$12.3M 5.95%
110,000
+35,000
+47% +$3.69M
GILD icon
3
Gilead Sciences
GILD
$168B
$11.8M 5.69%
125,000
+7,500
+6% +$776K
MDT icon
4
Medtronic
MDT
$110B
$9.03M 4.36%
125,000
-12,500
-9% -$868K
XLV icon
5
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$41.7B
$8.55M 4.13%
+125,000
New +$8.37M
XLRN
6
DELISTED
Acceleron Pharma
XLRN
$8.38M 4.05%
215,000
+190,000
+760% +$6.62M
ESPR
7
DELISTED
Esperion Therapeutics
ESPR
$8.09M 3.91%
200,000
+75,000
+60% +$2.3M
RCPT
8
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$6.13M 2.96%
50,000
VTRS icon
9
Viatris
VTRS
$20.6B
$5.64M 2.72%
100,000
+20,000
+25% +$1.07M
AMGN icon
10
Amgen
AMGN
$211B
$5.58M 2.69%
35,000
-46,500
-57% -$7.25M
ABBV icon
11
AbbVie
ABBV
$431B
$4.91M 2.37%
75,000
-50,000
-40% -$3.15M
XBI icon
12
PUT
State Street SPDR S&P Biotech ETF
XBI
$9.92B
$4.66M 2.25%
+75,000
New +$4.28M
SNY icon
13
Sanofi
SNY
$102B
$4.56M 2.2%
100,000
+85,000
+567% +$4.12M
AERI
14
DELISTED
Aerie Pharmaceuticals
AERI
$4.38M 2.12%
150,000
-40,000
-21% -$1.01M
MRK icon
15
Merck
MRK
$316B
$4.26M 2.06%
78,600
-5,240
-6% -$292K
SHPG
16
DELISTED
Shire pic
SHPG
$4.25M 2.05%
+20,000
New +$4.24M
SUPN icon
17
Supernus Pharmaceuticals
SUPN
$2.52B
$4.15M 2.01%
500,000
-100,000
-17% -$840K
GWPH
18
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$4.06M 1.96%
60,000
+10,000
+20% +$730K
TRNX
19
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$3.83M 1.85%
150,000
-25,000
-14% -$637K
THC icon
20
Tenet Healthcare
THC
$20.4B
$3.8M 1.84%
75,000
+32,500
+76% +$1.7M
VOLC
21
DELISTED
VOLCANO CORPORATION COM STK
VOLC
$3.58M 1.73%
+200,000
New +$2.4M
ETRM
22
DELISTED
EnteroMedics Inc.
ETRM
$3.47M 1.68%
2,328
+96
+4% +$130K
BIIB icon
23
PUT
Biogen
BIIB
$30.8B
$3.4M 1.64%
+10,000
New +$3.24M
AVNR
24
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$3.39M 1.64%
200,000
-25,000
-11% -$352K
PETX
25
DELISTED
Aratana Therapeutics, Inc.
PETX
$3.21M 1.55%
180,000
+30,000
+20% +$374K

Similar funds

Iguana Healthcare Management's Q4 2014 Portfolio in Review

As of Q4 2014, Iguana Healthcare Management held 83 positions worth $207M, up 11% from $187M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Iguana Healthcare Management's Q4 2014 filing shows 21 new, 16 increased, 17 reduced and 24 closed positions. Its largest new stake was Shire pic: 20,000 shares worth $4.25M. The largest sale was Amgen, an estimated $7.25M.

By sector, the portfolio is most concentrated in Healthcare at 71% of assets, down from 71% a quarter earlier.

  • Iguana Healthcare Management's largest Q4 2014 buy was Shire pic: 20,000 shares worth $4.25M.
  • Iguana Healthcare Management added most to Acceleron Pharma in Q4 2014, an estimated $6.62M increase.
  • Iguana Healthcare Management's biggest Q4 2014 reduction was Amgen, cutting an estimated $7.25M.
  • Iguana Healthcare Management fully exited Ionis Pharmaceuticals in Q4 2014, selling an estimated $3.3M.
  • Iguana Healthcare Management's ten largest holdings make up 43% of its $207M portfolio in Q4 2014.
  • Iguana Healthcare Management opened 21 new positions and closed 24 in Q4 2014.
  • Iguana Healthcare Management's portfolio value rose 11% quarter-over-quarter to $207M.

Based on Iguana Healthcare Management's 13F filing for Q4 2014, filed 18 Feb 2015.